BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33437951)

  • 1. Faecal microbiota transplantation for recurrent
    Baunwall SMD; Lee MM; Eriksen MK; Mullish BH; Marchesi JR; Dahlerup JF; Hvas CL
    EClinicalMedicine; 2020 Dec; 29-30():100642. PubMed ID: 33437951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
    Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH
    Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.
    Moayyedi P; Yuan Y; Baharith H; Ford AC
    Med J Aust; 2017 Aug; 207(4):166-172. PubMed ID: 28814204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy.
    Cold F; Baunwall SMD; Dahlerup JF; Petersen AM; Hvas CL; Hansen LH
    Therap Adv Gastroenterol; 2021; 14():17562848211041004. PubMed ID: 34484424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness of fecal microbiota transplantation for first or second Clostridioides difficile infection.
    Paaske SE; Dahl Baumwall SM; Rubak T; Birn FH; Rågård N; Kelsen J; Hansen MM; Svenningsen L; Krarup AL; Culmbach Fernis CM; Neumann A; Lødrup AB; Glerup H; Vinter-Jensen L; Helms M; Erikstrup LT; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
    Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38871148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Severe or Fulminant
    Song YN; Yang DY; Veldhuyzen van Zanten S; Wong K; McArthur E; Song CZ; Ianiro G; Cammarota G; Kelly C; Fischer M; Russell L; Kao D
    J Can Assoc Gastroenterol; 2022 Feb; 5(1):e1-e11. PubMed ID: 35118227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
    Tariq R; Hayat M; Pardi D; Khanna S
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1383-1392. PubMed ID: 33496893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
    Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
    Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Fecal Microbiota Transplant Failure in Clostridioides difficile Infection : An Updated Meta-analysis.
    Beran A; Sharma S; Ghazaleh S; Lee-Smith W; Aziz M; Kamal F; Acharya A; Adler DG
    J Clin Gastroenterol; 2023 Apr; 57(4):389-399. PubMed ID: 35050941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection - pilot prospective observational cohort study.
    Kachlíková M; Sabaka P; Koščálová A; Bendžala M; Dovalová Z; Stankovič I
    BMC Infect Dis; 2020 Jan; 20(1):52. PubMed ID: 31948404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis.
    Dembrovszky F; Gede N; Szakács Z; Hegyi P; Kiss S; Farkas N; Molnár Z; Imrei M; Dohos D; Péterfi Z
    Infect Dis Ther; 2021 Mar; 10(1):201-211. PubMed ID: 33106983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danish national guideline for the treatment of
    Baunwall SMD; Dahlerup JF; Engberg JH; Erikstrup C; Helms M; Juel MA; Kjeldsen J; Nielsen HL; Nilsson AC; Rode AA; Vinter-Jensen L; Hvas CL
    Scand J Gastroenterol; 2021 Sep; 56(9):1056-1077. PubMed ID: 34261379
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
    Rode AA; Chehri M; Krogsgaard LR; Heno KK; Svendsen AT; Ribberholt I; Helms M; Engberg J; Schønning K; Tvede M; Andersen CØ; Jensen US; Petersen AM; Bytzer P
    Aliment Pharmacol Ther; 2021 May; 53(9):999-1009. PubMed ID: 33694229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.
    Baunwall SMD; Terveer EM; Dahlerup JF; Erikstrup C; Arkkila P; Vehreschild MJ; Ianiro G; Gasbarrini A; Sokol H; Kump PK; Satokari R; De Looze D; Vermeire S; Nakov R; Brezina J; Helms M; Kjeldsen J; Rode AA; Kousgaard SJ; Alric L; Trang-Poisson C; Scanzi J; Link A; Stallmach A; Kupcinskas J; Johnsen PH; Garborg K; Rodríguez ES; Serrander L; Brummer RJ; Galpérine KT; Goldenberg SD; Mullish BH; Williams HR; Iqbal TH; Ponsioen C; Kuijper EJ; Cammarota G; Keller JJ; Hvas CL
    Lancet Reg Health Eur; 2021 Oct; 9():100181. PubMed ID: 34693388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
    Drekonja D; Reich J; Gezahegn S; Greer N; Shaukat A; MacDonald R; Rutks I; Wilt TJ
    Ann Intern Med; 2015 May; 162(9):630-8. PubMed ID: 25938992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.